Pharmacokinetics of Intravenous Immunoglobulin: A Systematic Review
- 1 June 2006
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 26 (6), 813-827
- https://doi.org/10.1592/phco.26.6.813
Abstract
Background. Intravenous immunoglobulin (IGIV) is used in the treatment of a wide variety of immune disorders. To our knowledge, no comprehensive or systematic review on the pharmacokinetics of IGIV has been published despite the availability of many published individual studies.This publication has 43 references indexed in Scilit:
- Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromesVox Sanguinis, 2003
- Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonatesThe Journal of Pediatrics, 1994
- Pharmacokinetics of Intravenous Immunoglobulin (Gammagard) in Bone Marrow Transplant PatientsThe Journal of Clinical Pharmacology, 1991
- NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of diseasePublished by American Medical Association (AMA) ,1990
- Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infantsThe Journal of Pediatrics, 1989
- Phannacokinetics of Intravenous Immunoglobulin in NeonatesVox Sanguinis, 1989
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988
- Pharmacokinetics and effectiveness of intravenous gammaglobulin in neonatesThe Journal of Pediatrics, 1988
- Disposition of an immunoglobulin intravenous preparation in very low birth weight neonatesThe Journal of Pediatrics, 1988
- Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonatesThe Journal of Pediatrics, 1987